REQUEST A DEMO
Total
USD $0.00
Search more companies

Inov8 I. Zebrowska sp. k. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Inov8 I. Zebrowska sp. k. Profile Updated: August 19, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Inov8 I. Zebrowska sp. k. is an enterprise in Poland, with the main office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on December 15, 2010. 6 - 20 (2012) employees currently work for Inov8 I. Zebrowska sp. k.. The company’s latest financial report indicates a net sales revenue increase of 23.44% in 2022. Its’ total assets recorded a negative growth of 3.23%. The enterprise’s net profit margin decreased by 4.48% in 2022.

Headquarters
Ul. Minska 48/1U
Warsaw; Mazowieckie; Postal Code: 03-808

Contact Details: Purchase the Inov8 I. Zebrowska sp. k. report to view the information.

Website: http://www.inov8-med.pl

Basic Information
Total Employees:
Purchase the Inov8 I. Zebrowska sp. k. report to view the information.
Outstanding Shares:
Purchase the Inov8 I. Zebrowska sp. k. report to view the information.
Incorporation Date:
December 15, 2010
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Inov8 I. Zebrowska sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
23.44%
Total operating revenue
23.51%
Operating profit (EBIT)
-18.58%
EBITDA
-15.49%
Net Profit (Loss) for the Period
-23.11%
Total assets
-3.23%
Total equity
7.76%
Operating Profit Margin (ROS)
-4.11%
Net Profit Margin
-4.48%
Return on Equity (ROE)
-25.84%
Quick Ratio
566.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?